Post-Vaccinal Encephalitis with Early Relapse after BNT162b2 (COMIRNATY) COVID-19 Vaccine: A Case Report

We describe the case of a 72-year-old man who received the first dose of the BNT162b2 (COMIRNATY) vaccine against COVID-19 on 18 May 2021, and the second dose on 9 September 2021. One day after receiving the first dose, he cursed with malaise, headache, fever, confusion, aggressiveness, and gait alt...

Descripción completa

Detalles Bibliográficos
Autores principales: Vences, Miguel A., Canales, Diego, Albujar, Maria Fe, Barja, Ebelin, Araujo-Chumacero, Mary M., Cardenas, Edu, Alvarez, Arturo, Urrunaga-Pastor, Diego
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318781/
https://www.ncbi.nlm.nih.gov/pubmed/35891229
http://dx.doi.org/10.3390/vaccines10071065

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318781/
https://www.ncbi.nlm.nih.gov/pubmed/35891229
http://dx.doi.org/10.3390/vaccines10071065

Ejemplares similares